146944-27-6 Usage
Uses
Used in Pharmaceutical Industry:
(4-Benzyl-morpholin-2-yl)-acetic acid is used as a reactant for the synthesis of 4-sulfonylmorpholine derivatives, which are crucial in developing inhibitors for human 11-β-hydroxy steroid dehydrogenase type 1. These inhibitors have potential applications in treating various medical conditions related to the enzyme's function.
Used in Research and Development:
In the field of research and development, (4-Benzyl-morpholin-2-yl)-acetic acid is utilized as a key compound in the study and understanding of the enzyme human 11-β-hydroxy steroid dehydrogenase type 1. This knowledge can lead to the development of novel therapeutic strategies and treatments for related health issues.
Check Digit Verification of cas no
The CAS Registry Mumber 146944-27-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,6,9,4 and 4 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 146944-27:
(8*1)+(7*4)+(6*6)+(5*9)+(4*4)+(3*4)+(2*2)+(1*7)=156
156 % 10 = 6
So 146944-27-6 is a valid CAS Registry Number.
InChI:InChI=1/C13H17NO3/c15-13(16)8-12-10-14(6-7-17-12)9-11-4-2-1-3-5-11/h1-5,12H,6-10H2,(H,15,16)
146944-27-6Relevant articles and documents
A COMPOUND FOR INHIBITING HUMAN 11-β-HYDROXY STEROID DEHYDROGENASE TYPE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
-
Page/Page column 45-46, (2012/10/08)
The present invention relates to a novel compound, or a stereoisomer, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition for human-11-beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) comprising the same. The invention provides a compound, which has excellent activity and solubility and is more efficiently formulated and delivered, and a pharmaceutical composition for human-11-beta-hydroxysteroid dehydrogenase type 1 comprising the same.
Quinolone antimicrobial agents substituted with morpholines at the 7- position. Syntheses and structure-activity relationships
Araki,Kuroda,Uemori,Moriguchi,Ikeda,Hirayama,Yokoyama,Iwao,Yakushiji
, p. 1356 - 1363 (2007/10/02)
A series of novel 7-substituted 1-cyclopropyl-6,8-difluoro-1,4-dihydro-4- oxo-3-quinolinecarboxylic acids have been prepared and tested for antibacterial activities and for convulsive activities in combination with nonsteroidal antiinflammatory drug. Stru